Bijan Zakeri

Global Technical Marketing Manager Consulate General of Canada (CTA Boston)

  • Boston MA

Bijan Zakeri is a pharmaceutical industry professional with a strong business acumen, scientific expertise and technical marketing.

Contact

Consulate General of Canada (CTA Boston)

View more experts managed by Consulate General of Canada (CTA Boston)

Social

Biography

Bijan Zakeri is an experienced pharmaceutical industry professional with a passion for coming up with innovative solutions to difficult challenges. Working at the intersection of business and technology, he drives strategic change within organizations through identifying market needs and understanding the voice of the customer to produce new business development opportunities. Bijan is experienced in business management, technical marketing, business development, project management, and people management. He has extensive international experience and experience in working in a large multi-national organization, in addition to his strong business acumen, scientific expertise, and communication skills.

Industry Expertise

Pharmaceuticals

Areas of Expertise

Drug Discovery
Pharmaceutical Industry
Biochemistry
Protein Chemistry
Biotechnology
Drug Development

Education

McMaster University

B.Sc.

Biochemistry

McMaster University

M.Sc.

Chemical Biology

University of Oxford

Ph.D.

Biochemistry

Multimedia

Links

Selected Media Appearances

From flesh eating bacteria to molecular superglue

TED Talks  online

Scientist Bijan Zakeri started studying Streptococcus pyogenes -- the pathogen responsible for diseases from strep throat to scarlet fever -- in the hopes of creating a new generation of antibodies to treat cancer. What he developed instead was completely unexpected: a molecular superglue made from its stone-strong chemical bonds that may change the way we address scientific and medical needs.

View More

Selected Articles

Superglue from Bacteria: Unbreakable Bridges for Protein Nanotechnology

Trends in Biotechnology

2014
Biotechnology is often limited by weak interactions. We suggest that an ideal interaction between proteins would be covalent, specific, require addition of only a peptide tag to the protein of interest, and form under a wide range of conditions. Here we summarize peptide tags that are able to form spontaneous amide bonds, based on harnessing reactions of adhesion proteins from the bacterium Streptococcus pyogenes. These include the irreversible peptide–protein interaction of SpyTag with SpyCatcher, as well as irreversible peptide–peptide interactions via SpyLigase. We describe existing applications, including polymerization to enhance cancer cell capture, assembly of living biomaterial, access to diverse protein shapes, and improved enzyme resilience. We also indicate future opportunities for resisting biological force and extending the scope of protein nanotechnology.

View more

The Limits of Synthetic Biology

Trends in Biotechnology

2014
The pioneering works of Watson, Crick, Wilkins, and Franklin [1,2] on the structure of DNA have captivated our imaginations for over half a century and continue to shape our future endeavors. The genetic code, a mystery for many years, was soon thereafter decoded by organic chemists employing organic synthesis of polynucleotides [3]. Ever since, the construction of DNA has been central to our ability to probe the molecular nature of life. Synthetic biologists now push the limits of what can be engineered using DNA – from scratch if needed: complex genetic circuits, large metabolic pathways, and even whole genomes.

View more

Synthetic Biology: A New Tool for the Trade

ChemBioChem

2015
Protein-protein interactions are fundamental to many biological processes. Yet the weak and transient non-covalent bonds that characterize most protein-protein interactions found in nature impose limits on many bioengineering experiments. Here a new class of genetically encodable peptide-protein pairs-isopeptag-N/pilin-N, isopeptag/pilin-C, and SpyTag-SpyCatcher-that interact via autocatalytic intermolecular isopeptide bond formation is described. Reactions between peptide-protein pairs are specific, robust, orthogonal, and able to proceed under most biologically relevant conditions both in vitro and in vivo. As fusion constructs they provide a handle on molecules of interest, both organic and inorganic, that can be grasped with an iron grip. Such stable interactions provide robust post-translational control over biological processes, and open new opportunities in synthetic biology for engineering programmable and self-assembling protein nanoarchitectures

View more

Show All +